RhumbLine Advisers
BIVV

RhumbLine Advisers’s Bioverativ Inc. Common Stock BIVV Stock Holding History

RhumbLine Advisers’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-243,432
Closed -$13.1M – 2833
2017
Q4 		$13.1M Sell
243,432
-4,092
-2% -$224K 0.03% 582
2017
Q3 		$14.1M Buy
247,524
+25,994
+12% +$1.52M 0.03% 539
2017
Q2 		$13.3M Buy
221,530
+23,718
+12% +$1.35M 0.03% 534
2017
Q1 		$10.8M Buy
+197,812
New +$9.74M 0.03% 617

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

RhumbLine Advisers's BIVV Position: Q1 2018 in Review

RhumbLine Advisers sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 243,432 shares — an estimated $13.1M sold.

RhumbLine Advisers first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $14.1M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • RhumbLine Advisers reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • RhumbLine Advisers sold 243,432 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $13.1M.
  • RhumbLine Advisers first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • RhumbLine Advisers's Bioverativ Inc. Common Stock position peaked at $14.1M in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on RhumbLine Advisers's 13F filing for Q1 2018, filed 2 May 2018.